glp-1 and thyroid cancer Do Ozempic Mounjaro increase the risk of cancer? It's a question that's come up often, and I'm here to set the record straight. While early animal studies raised concerns about GLP-1 Medications & Thyroid Disease

Cornelison DD, Filla MS, Stanley HM, Rapraeger AC, Olwin BB: Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration

Labs to Monitor Fasting IGF-1 level: Baseline before cycle, and mid-cycle

Maier JA, et al

Currently, there are three GLP-1 receptor agonists on the market: dulaglutide (Trulicity) liraglutide (Victoza) semaglutide (Ozempic and Rybelsus) There's also a similar medication called tirzepatide (Mounjaro, Zepbound), which is a dual GLP-1/GIP receptor agonist

It helps in maintaining a healthy cardiovascular system by aiding in the metabolism of fatty acids, which can reduce the accumulation of fatty deposits in the arteries

It potentially selectively attaches to ghrelin receptors in laboratory models during clinical trials